NO20064659L - Nye kvarterniserte quinuklidin-estere - Google Patents

Nye kvarterniserte quinuklidin-estere

Info

Publication number
NO20064659L
NO20064659L NO20064659A NO20064659A NO20064659L NO 20064659 L NO20064659 L NO 20064659L NO 20064659 A NO20064659 A NO 20064659A NO 20064659 A NO20064659 A NO 20064659A NO 20064659 L NO20064659 L NO 20064659L
Authority
NO
Norway
Prior art keywords
compounds
new
quinuclidine esters
urological
respiratory
Prior art date
Application number
NO20064659A
Other languages
English (en)
Norwegian (no)
Inventor
Maria Dolors Fernandez Forner
Maria Prat Quinones
Maria Antonia Buil Albero
Original Assignee
Almirall Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Almirall Lab filed Critical Almirall Lab
Publication of NO20064659L publication Critical patent/NO20064659L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D453/00Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
    • C07D453/02Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/439Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/02Nasal agents, e.g. decongestants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/06Antiasthmatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/02Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/10Drugs for disorders of the urinary system of the bladder
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/06Antiarrhythmics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Urology & Nephrology (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Oncology (AREA)
  • Rheumatology (AREA)
  • Communicable Diseases (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Otolaryngology (AREA)
  • Cardiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO20064659A 2004-03-15 2006-10-13 Nye kvarterniserte quinuklidin-estere NO20064659L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ES200400638A ES2239546B1 (es) 2004-03-15 2004-03-15 Nuevos esteres de quinuclidina cuaternizados.
PCT/EP2005/002523 WO2005090342A1 (fr) 2004-03-15 2005-03-10 Nouveaux esters de quinuclidine quaternises

Publications (1)

Publication Number Publication Date
NO20064659L true NO20064659L (no) 2006-12-13

Family

ID=34955916

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20064659A NO20064659L (no) 2004-03-15 2006-10-13 Nye kvarterniserte quinuklidin-estere

Country Status (30)

Country Link
US (1) US20080214600A1 (fr)
EP (1) EP1725552B1 (fr)
JP (1) JP2007529444A (fr)
KR (1) KR20070003940A (fr)
CN (1) CN1930158A (fr)
AR (1) AR048004A1 (fr)
AT (1) ATE399166T1 (fr)
AU (1) AU2005223310A1 (fr)
BR (1) BRPI0508177A (fr)
CA (1) CA2560157A1 (fr)
CY (1) CY1108324T1 (fr)
DE (1) DE602005007714D1 (fr)
DK (1) DK1725552T3 (fr)
EC (1) ECSP066770A (fr)
ES (2) ES2239546B1 (fr)
HR (1) HRP20080338T3 (fr)
IL (1) IL177341A0 (fr)
MY (1) MY142036A (fr)
NO (1) NO20064659L (fr)
NZ (1) NZ548583A (fr)
PE (1) PE20060005A1 (fr)
PL (1) PL1725552T3 (fr)
PT (1) PT1725552E (fr)
RS (1) RS50566B (fr)
RU (1) RU2382041C2 (fr)
SI (1) SI1725552T1 (fr)
TW (1) TW200604196A (fr)
UA (1) UA88634C2 (fr)
WO (1) WO2005090342A1 (fr)
ZA (1) ZA200605931B (fr)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2165768B1 (es) 1999-07-14 2003-04-01 Almirall Prodesfarma Sa Nuevos derivados de quinuclidina y composiciones farmaceuticas que los contienen.
GB0424284D0 (en) * 2004-11-02 2004-12-01 Novartis Ag Organic compounds
ES2298049B1 (es) * 2006-07-21 2009-10-20 Laboratorios Almirall S.A. Procedimiento para fabricar bromuro de 3(r)-(2-hidroxi-2,2-ditien-2-ilacetoxi)-1-(3-fenoxipropil)-1-azoniabiciclo (2.2.2) octano.
JP2010519193A (ja) * 2007-02-15 2010-06-03 アージェンタ ディスカバリー リミテッド M3ムスカリン受容体としての複素環式誘導体
JP5656288B2 (ja) 2007-09-07 2015-01-21 セラヴァンス バイオファーマ アール&ディー アイピー, エルエルシー ムスカリン受容体アンタゴニストとして有用なグアジニン含有化合物
CA2608561A1 (fr) * 2007-10-29 2009-04-29 Carl Paluszkiewicz Support d'accessoires de deflecteur pour motocyclette
EP2222637A1 (fr) 2007-12-14 2010-09-01 Theravance, Inc. Composés contenant de l'amidine utiles comme antagonistes du récepteur muscarinique
EP2100598A1 (fr) * 2008-03-13 2009-09-16 Laboratorios Almirall, S.A. Composition à inhaler comprenant aclidinium pour le traitement de l'asthme et de maladies respiratoires obstructives chroniques
EP2100599A1 (fr) 2008-03-13 2009-09-16 Laboratorios Almirall, S.A. Composition à inhaler comprenant aclidinium pour le traitement de l'asthme et de maladies respiratoires obstructives chroniques
US20090326004A1 (en) 2008-06-03 2009-12-31 Ranbaxy Laboratories Limited Muscarinic receptor antagonists
PL2417106T3 (pl) 2009-04-09 2017-05-31 Novartis Ag Sposób wytwarzania soli pirolidyniowych
EP2510928A1 (fr) 2011-04-15 2012-10-17 Almirall, S.A. Aclidinium pour l'amélioration du sommeil des patients avec des maldadies respiratoires
KR20150092173A (ko) * 2012-12-05 2015-08-12 키에시 파르마슈티시 엣스. 피. 에이. Pde4-억제제로서 페닐에틸피리딘 유도체
CN103755699A (zh) * 2014-01-06 2014-04-30 万特制药(海南)有限公司 一种2-羟基-2,2-二噻吩-2-基乙酸-1-氮杂二环[2,2,2]辛-3(r)-基酯制备方法
CN103755698A (zh) * 2014-01-06 2014-04-30 万特制药(海南)有限公司 一锅法制备阿地溴铵的工艺
KR101511090B1 (ko) 2014-04-24 2015-04-10 고려대학교 산학협력단 염증성 질환의 예방 또는 치료용 약학 조성물

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1219606A (en) * 1968-07-15 1971-01-20 Rech S Et D Applic Scient Soge Quinuclidinol derivatives and preparation thereof
US4843074A (en) * 1988-05-17 1989-06-27 Marion Laboratories, Inc. 1-azabicyclo[2.2.2]octan-3-yl 2-aryl-3-azacyclo-2-hydroxypropionates and their quaternary salts
NO2005012I1 (no) * 1994-12-28 2005-06-06 Debio Rech Pharma Sa Triptorelin og farmasoytisk akseptable salter derav
ES2165768B1 (es) * 1999-07-14 2003-04-01 Almirall Prodesfarma Sa Nuevos derivados de quinuclidina y composiciones farmaceuticas que los contienen.
WO2002053564A2 (fr) * 2000-12-28 2002-07-11 Almirall Prodesfarma Ag Nouveaux derives de quinuclidine et compositions medicinales contenant ces derniers
KR20050030169A (ko) * 2001-10-17 2005-03-29 유씨비 소시에떼아노님 퀴누클리딘 유도체, 이의 제조 방법 및 m2 및/또는 m3무스카린 수용체 억제제로서의 이의 용도
ES2204295B1 (es) * 2002-07-02 2005-08-01 Almirall Prodesfarma, S.A. Nuevos derivados de quinuclidina-amida.
AR044134A1 (es) * 2003-05-02 2005-08-24 Novartis Ag Derivados de quinuclidina, metodo de preparacion y composiciones farmaceuticas.

Also Published As

Publication number Publication date
JP2007529444A (ja) 2007-10-25
IL177341A0 (en) 2006-12-10
RU2382041C2 (ru) 2010-02-20
US20080214600A1 (en) 2008-09-04
ES2239546A1 (es) 2005-09-16
ZA200605931B (en) 2007-11-28
AR048004A1 (es) 2006-03-15
RU2006136085A (ru) 2008-04-27
AU2005223310A1 (en) 2005-09-29
TW200604196A (en) 2006-02-01
HK1101855A1 (en) 2007-10-26
HRP20080338T3 (hr) 2008-07-31
CN1930158A (zh) 2007-03-14
DE602005007714D1 (de) 2008-08-07
DK1725552T3 (da) 2008-10-13
ES2307168T3 (es) 2008-11-16
NZ548583A (en) 2010-05-28
EP1725552A1 (fr) 2006-11-29
WO2005090342A1 (fr) 2005-09-29
ATE399166T1 (de) 2008-07-15
PT1725552E (pt) 2008-09-18
ECSP066770A (es) 2006-11-16
KR20070003940A (ko) 2007-01-05
CA2560157A1 (fr) 2005-09-29
CY1108324T1 (el) 2014-02-12
MY142036A (en) 2010-08-16
SI1725552T1 (sl) 2008-10-31
EP1725552B1 (fr) 2008-06-25
BRPI0508177A (pt) 2007-08-07
UA88634C2 (en) 2009-11-10
PE20060005A1 (es) 2006-01-28
RS50566B (sr) 2010-05-07
ES2239546B1 (es) 2006-12-01
PL1725552T3 (pl) 2008-12-31

Similar Documents

Publication Publication Date Title
WO2012016186A8 (fr) Inhibiteurs de kinases macrocycliques et leurs utilisations
NO20082709L (no) Kjemiske forbindelser
NO20073719L (no) Kjemiske forbindelser
NO20064659L (no) Nye kvarterniserte quinuklidin-estere
NO20090755L (no) Amino-imidazoloner og deres anvendelse som et medikament for behandling av kognitiv svekkelse, Alzheimers sykdom, neurodegenerering og demens
NO20090166L (no) Amino-imidazoloner og deres anvendelse som et medikament for behandling av kognitiv svekkelse, Alzheimers sykdom, neurodegenerering og demens
UA113051C2 (xx) Гетероциклічні похідні та їх застосування у лікуванні неврологічних розладів
NO20082673L (no) Nye 2-amino-imidazol-4-on forbindelser og deres anvendelse i fremstilling av et medikament som skal brukes til behandling av kognitiv svekkelse, Alzheimers sykdom, neurodegenerasjon og demens
DK2150530T3 (da) Substituerede sulfonamid-derivater
NO20091599L (no) Kjemiske forbindelser
NO20074592L (no) Acetylenyl-pyrazolo-pyrimidinderivater som mGluR2-antagonister
WO2012162254A8 (fr) Inhibiteurs de l'activité lrrk2 kinase
WO2008094992A3 (fr) Inhibiteurs de kinase
NO20082124L (no) Bifenyloksyeddiksyrederivater for behandling av respiratorisk sykdom
NO20081315L (no) Benzokinazolinderivater og deres anvendelse ved behandling av benlidelser
NO20091683L (no) Kjemiske forbindelser
WO2009050242A3 (fr) Pipérazino-dihydrothiénopyrimidines substituées par un hétérocycle
TW200635899A (en) Chemical compounds
NO20070445L (no) Pyrimidinderivater.
WO2012048129A3 (fr) Inhibiteurs de kinase de type polo
GEP20084452B (en) Sulfonamide derivatives for the treatment of diseases
WO2006099943A8 (fr) 8-n-benzimidazoles a substitution amide, leur procede de production, et leur utilisation en tant que medicaments
NO20082690L (no) Kjemiske forbindelser
NO20075637L (no) 4-fenyl-5-okso-1,4,5,6,7,8-heksahydrokinolinderivater som medikamenter for behandling av infertilitet
NO20083853L (no) Nye forbindelser

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application